Literature DB >> 33452336

Estimating the health burden of aflatoxin attributable stunting among children in low income countries of Africa.

Hifza Rasheed1,2, Ya Xu3, Martin E Kimanya4, Xiaoxi Pan3, Zhihua Li5, Xiaobo Zou5, Candida P Shirima6, Melvin Holmes1, Michael N Routledge7,8, Yun Yun Gong9.   

Abstract

Numerous population-based studies have documented high prevalence of aflatoxin associated childhood stunting in low income countries. We provide an estimate of the disease burden of aflatoxin related stunting using data from the four African countries. For this empirical analysis, we obtained blood aflatoxin albumin adduct biomarker based exposure data as measured using ELISA technique and anthropometric measurement data from surveys done over a 12-year period from 2001 to 2012 in four low income countries in Africa. We used these data to calculate population attributable risk (PAR), life time disease burden for children under five by comparing two groups of stunted children using both prevalence and incidence-based approaches. We combined prevalence estimates with a disability weight, measuring childhood stunting and co-occurrence of stunting-underweight to produce years lived with disability. Using a previously reported mortality, years of life lost were estimated. We used probabilistic analysis to model these associations to estimate the disability-adjusted life-years (DALYs), and compared these with those given by the Institute for Health Metrics and Evaluation's Global Burden of Disease (GBD) 2016 study. The PAR increased from 3 to 36% for aflatoxin-related stunting and 14-50% for co-occurrence of stunting and underweight. Using prevalence-based approach, children with aflatoxin related stunting resulted in 48,965.20 (95% uncertainty interval (UI): 45,868.75-52,207.53) DALYs per 100,000 individuals. Children with co-occurrence of stunting and underweight due to exposure to aflatoxin resulted in 40,703.41 (95% UI: 38,041.57-43,517.89) DALYs per 100,000 individuals. Uncertainty analysis revealed that reducing aflatoxin exposure in high exposure areas upto non-detectable levels could save the stunting DALYs up to 50%. The burden of childhood all causes stunting is greater in countries with higher aflatoxin exposure such as Benin. In high exposure areas, these results might help guide research protocols and prioritisation efforts and focus aflatoxin exposure reduction. HEFCE Global Challenge Research Fund Aflatoxin project.

Entities:  

Year:  2021        PMID: 33452336      PMCID: PMC7810982          DOI: 10.1038/s41598-020-80356-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  50 in total

1.  Aflatoxins in breast milk, neonatal cord blood, and serum of pregnant women.

Authors:  S M Lamplugh; R G Hendrickse; F Apeagyei; D D Mwanmut
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

Review 2.  The toxicology of aflatoxins as a basis for public health decisions.

Authors:  C P Wild; P C Turner
Journal:  Mutagenesis       Date:  2002-11       Impact factor: 3.000

3.  Co-contamination of aflatoxin B1 and fumonisin B1 in food and human dietary exposure in three areas of China.

Authors:  G Sun; S Wang; X Hu; J Su; Y Zhang; Y Xie; H Zhang; L Tang; J-S Wang
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2011-01-18

4.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

5.  Dietary aflatoxin-induced stunting in a novel rat model: evidence for toxin-induced liver injury and hepatic growth hormone resistance.

Authors:  Brittany Knipstein; Jiansheng Huang; Emily Barr; Philip Sossenheimer; Dennis Dietzen; Patricia A Egner; John D Groopman; David A Rudnick
Journal:  Pediatr Res       Date:  2015-05-04       Impact factor: 3.756

6.  Cost-effectiveness of prenatal food and micronutrient interventions on under-five mortality and stunting: Analysis of data from the MINIMat randomized trial, Bangladesh.

Authors:  Pernilla Svefors; Katarina Ekholm Selling; Rubina Shaheen; Ashraful Islam Khan; Lars-Åke Persson; Lars Lindholm
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

7.  Reflections on the global burden of disease 2010 estimates.

Authors:  Peter Byass; Maximilian de Courten; Wendy J Graham; Lucie Laflamme; Affette McCaw-Binns; Osman A Sankoh; Stephen M Tollman; Basia Zaba
Journal:  PLoS Med       Date:  2013-07-02       Impact factor: 11.069

8.  Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies.

Authors:  Ibironke Olofin; Christine M McDonald; Majid Ezzati; Seth Flaxman; Robert E Black; Wafaie W Fawzi; Laura E Caulfield; Goodarz Danaei
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

9.  Modification of immune function through exposure to dietary aflatoxin in Gambian children.

Authors:  Paul C Turner; Sophie E Moore; Andrew J Hall; Andrew M Prentice; Christopher P Wild
Journal:  Environ Health Perspect       Date:  2003-02       Impact factor: 9.031

10.  Aflatoxin-related immune dysfunction in health and in human immunodeficiency virus disease.

Authors:  Yi Jiang; Pauline E Jolly; Peter Preko; Jia-Sheng Wang; William O Ellis; Timothy D Phillips; Jonathan H Williams
Journal:  Clin Dev Immunol       Date:  2008
View more
  1 in total

1.  Aflatoxin B1 Metabolism of Reared Alphitobius diaperinus in Different Life-Stages.

Authors:  Nathan Meijer; Rosalie Nijssen; Marlou Bosch; Ed Boers; H J van der Fels-Klerx
Journal:  Insects       Date:  2022-04-06       Impact factor: 3.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.